EUVIMEDEUVIMED entdecken
Crossref

TRIB2-Mediated Modulation of AMPK Promotes Hepatic Insulin Resistance

Dan Wang, Xiaonan Kang, Lu Zhang, Yaoyao Guo, Ziyin Zhang, Huihui Ren, Gang Yuan iD

Diabetes · 2024

DOI: 10.2337/db23-0195 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, 2024. Verfasst von Dan Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, People's Republic …. Hauptthemen laut MEDLINE: Insulin Resistance, Liver, Mice, Knockout, Diet, High-Fat. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Insulin resistance and its linked health complications are increasing in prevalence. Recent work has caused the role of Tribbles2 (TRIB2) in metabolism and cellular signaling to be increasingly appreciated, but its role in the progression of insulin resistance has not been elucidated. Here, we explore the functions of TRIB2 in modulating insulin resistance and the mechanism involved in insulin-resistant mice and palmitic acid–treated HepG2 cells. We demonstrate that whole-body knockout and hepatic-specific TRIB2 deficiency protect against diet-induced insulin resistance, inflammation, and endoplasmic reticulum stress. Accordingly, upregulation of TRIB2 in the liver aggravates these metabolic disturbances in high-fat diet–induced mice and ob/ob mice. Mechanistically, TRIB2 directly binds to the αγ-SBS domain of PRKAB through its pseudokinase domain, subsequently inhibiting the formation and activity of the AMPK complex. Moreover, the results of intervention against AMPK suggest that the effects of TRIB2 depend on AMPK. Our findings reveal that TRIB2 is a novel target for the treatment of insulin resistance and its associated metabolic complications and clarify the function of TRIB2 as a regulatory component of AMPK activity. Article Highlights

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Insulin ResistanceLiverMice, KnockoutDiet, High-FatAMP-Activated Protein KinasesAnimalsHumansMiceHep G2 CellsProtein Serine-Threonine KinasesIntracellular Signaling Peptides and ProteinsEndoplasmic Reticulum StressMaleMice, Inbred C57BLCalcium-Calmodulin-Dependent Protein Kinases

Substanzen

AMP-Activated Protein KinasesProtein Serine-Threonine Kinasestribbles 2 protein, mouseIntracellular Signaling Peptides and ProteinsTRIB2 protein, humanCalcium-Calmodulin-Dependent Protein Kinases

Autor:innen und Institutionen

  • Department of Endocrinology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, People's Republic of China.
  • Clinical Research Center for Metabolic Disease, Wuhan, Hubei, People's Republic of China.

ORCID-Profile: Gang Yuan

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Wang, D., Kang, X., Zhang, L., Guo, Y., Zhang, Z., Ren, H., & Yuan, G. (2024). TRIB2-Mediated Modulation of AMPK Promotes Hepatic Insulin Resistance. Diabetes. https://doi.org/10.2337/db23-0195

Vancouver

Wang D, Kang X, Zhang L, Guo Y, Zhang Z, Ren H, et al. TRIB2-Mediated Modulation of AMPK Promotes Hepatic Insulin Resistance. Diabetes. 2024. doi:10.2337/db23-0195

BibTeX
@article{Wang2024,
  author = {Wang, Dan and Kang, Xiaonan and Zhang, Lu and Guo, Yaoyao and Zhang, Ziyin and Ren, Huihui and Yuan, Gang},
  title = {TRIB2-Mediated Modulation of AMPK Promotes Hepatic Insulin Resistance},
  journal = {Diabetes},
  year = {2024},
  doi = {10.2337/db23-0195}
}
Kostenlos starten →